Search

Displaying results 6081 - 6090 of 9702 in total
  1. Drug

    PT217

    go.drugbank.com/drugs/DB18472
    Investigational

    PT217 is a bispecific Antibody against DLL3 and CD47

  2. Drug

    ASP-2138

    go.drugbank.com/drugs/DB18473
    Investigational

    ASP-2138 is a bispecific antibody directed against CLDN18.2 and T cell receptor complex CD3

  3. Drug

    VBI-1901

    go.drugbank.com/drugs/DB18476
    Investigational

    VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles

  4. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    ALT-P1 is a long-acting recombinant human growth hormone fused to an alpha1-antitrypsin variant. It is under investigation for the treatment of growth hormone deficiency.

  5. Drug

    KT-253

    go.drugbank.com/drugs/DB18487
    Investigational

    KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).

  6. Drug

    DMP-777

    go.drugbank.com/drugs/DB18488
    Experimental

    DMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase.

  7. Drug

    Elenestinib

    go.drugbank.com/drugs/DB18489
    Investigational

    Elenestinib is a selective KIT inhibitor.

  8. Drug

    LTI-03

    go.drugbank.com/drugs/DB18491
    Investigational

    LTI-03 is a caveolin-1 Scaffolding Domain 7-Mer

    Synonyms: L-threonine, l-phenylalanyl-l-threonyl-l-threonyl-l-phenylalanyl-l-threonyl-l-valyl-
  9. Drug

    STP-707

    go.drugbank.com/drugs/DB18499
    Investigational

    STP-707 is a small interfering RNA (siRNA) targeting TGF-Beta1 and COX-2 mRNA.

  10. Drug

    ISP-001

    go.drugbank.com/drugs/DB18501
    Investigational

    ISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and delivery of alpha-L-iduronidase.